The 10-year plan would provide coverage to more than 30 million people now uninsured through a combination of tax credits for middle class households and an expansion of the Medicaid program for low income people. Release of the legislation later Thursday sets the stage for a House vote on Sunday.

It would restructure one-sixth of the U.S. economy in the biggest expansion of the social safety net since Medicare was created in 1965. It would also impose new obligations on individuals and businesses, requiring for the first time that most Americans carry health insurance and penalizing medium-sized and large companies that don't provide coverage for their workers.

Hospitals and doctors, drug companies and insurers would gain millions of new paying customers, but they would also have to adjust to major changes. Medicare cuts would force hospitals to operate more efficiently or risk going out of business. Insurance companies would face unprecendented federal regulation. Health care industries would be hit with new federal taxes. Upper-income households would face a new tax on investment earnings.

AstraZeneca says a jury in Middlesex County Superior Court in New Jersey ruled in favor of the drugmaker.

The case was brought by a 61-year-old Louisiana man who claims he developed diabetes after taking the drug for a few years. Ted Baker, a Vietnam veteran, took Seroquel from 2001 through 2006.

The drug is approved for treating schizophrenia and bipolar disorder. It's been on the market since 1997 and brings in more than $4 billion in annual sales.

Nine other cases brought by plaintiffs in New Jersey, Delaware and Florida have been dismissed before the start of a trial.

All the men argued that the state violated their Sixth Amendment due process rights because they were sentenced to death by a judge instead of a jury, as required under the 2002 federal decision.

But in a unanimous ruling handed down Friday, the Idaho Supreme Court noted that their cases were all appealed and the judgments made final before the U.S. Supreme Court ruling was issued — and that 2002 decision can't be retroactively applied to the Idaho inmates' cases.

All six inmates have appeals in various stages of state and federal court that will now move forward.

Obama on Wednesday tapped Amy Totenberg for a seat on the U.S. District Court for the Northern District of Georgia. She has been in private practice and has served as an arbitrator in Atlanta since 2000.

The Harvard Law School graduate also is a special master in federal court in Maryland and a court monitor in federal court in the District of Columbia.

U.S. District Judge James B. Zagel also dismissed defense attorneys' concerns that U.S. Supreme Court decisions expected by the end of June could unfairly complicate the trial.

Zagel said he saw no reason to delay the trial's June 3 start date.

If the date holds, voters will likely hear months of testimony about the former Democratic governor's alleged misdeeds as the party tries to retain his former seat and the U.S. Senate seat once held by President Barack Obama.

Prosecutors say Blagojevich schemed to sell or trade that Senate seat and used his power to illegally pressure political campaign donors.

Blagojevich has pleaded not guilty to racketeering conspiracy and other charges.

The verdict came Tuesday after a weeklong trial in U.S. District Court for the Eastern District of Texas.

Lawyers for VirnetX, which is based in Scotts Valley, say the $105.75 million verdict was $71.75 million for infringing one patent, and $34 million for infringing another.

The patents cover ways to establish virtual private network, or VPN, connections, which are used to protect Internet and other data traffic from snoops. The traffic is generally encrypted, or scrambled so outsiders can't decipher it.

Microsoft says it is disappointed by the jury's verdict and that it believes it didn't infringe the patents. It says it will appeal.

A federal judge on Tuesday said farmers can harvest their genetically engineered sugar beets this year, ruling the economic impact too great and that environmental groups waited too long to request that the crop be yanked from the ground and otherwise barred from the market.

Nearly all sugar beets planted are genetically engineered and the crop accounts for half the nation's sugar supply.

U.S. District Court Judge Jeffrey White last year sided with the environmental groups when he ruled that federal regulators five years ago improperly approved the genetically engineered crop for market. White said in September that further environmental studies are required before the United States Department of Agriculture can decide the issue but didn't decide the next legal steps.

In January, the Center for Food Safety, Earthjustice and several other groups and organic farmers asked White to immediately halt the planting and harvest of all genetically engineered beets while determining how to resolve the lawsuit, which was filed in 2007.

The groups sued the USDA over its approval, and the biotech company Monsanto Co., which develops genetically engineered seeds, joined the lawsuit on the government's side.

The groups and organic farmers fear the biotech beets will cross-pollinate with conventional beets, as well as Swiss chard, and upset consumers who shun genetically engineered products.